Prevounce Health

Prevounce Health Competitive Intelligence & Landscape

prevounce.com ·

Overview

Prevounce Health Overview

Prevounce Health is a healthcare technology company that specializes in remote care management solutions, focusing on improving patient engagement and healthcare delivery through innovative digital tools (Prevounce). Founded with the mission to enhance healthcare accessibility and efficiency, the company offers a comprehensive remote patient monitoring system that leverages AI-powered insights to optimize patient care and outcomes (Prevounce).

Headquartered in the United States, Prevounce Health targets healthcare providers, clinics, and health systems seeking to implement remote care strategies, especially in the context of telehealth and digital health transformation (CB Insights). The company's core products include its remote patient monitoring platform, which integrates AI and data analytics to deliver real-time insights and improve clinical decision-making (Prevounce). As of 2026, Prevounce continues to expand its offerings and market reach, supported by recent funding rounds and product innovations (Prevounce).

Prevounce Health

Prevounce Health Weekly Intel Updates

Receive weekly intel updates about Prevounce Health straight to your inbox.

Competitors

Prevounce Health Competitors

Prevounce Health operates in the healthcare management software market, competing with several notable players that differentiate themselves through features, market positioning, and pricing strategies.

1health is a key competitor known for its comprehensive healthcare solutions that integrate telehealth, patient engagement, and revenue cycle management. It emphasizes ease of use and scalability, targeting both small clinics and large healthcare systems, and offers competitive pricing with a focus on improving operational efficiency (CB Insights).

MedSys Health specializes in electronic health records (EHR) and practice management solutions. Its key differentiator is tailored workflow automation and robust compliance features, appealing to hospitals and clinics seeking customizable solutions. MedSys positions itself as a cost-effective alternative with a strong focus on data security and interoperability (Software Finder).

PharmD Live is distinct as a telepharmacy platform that supports remote medication management and pharmacy operations. Its market niche is in pharmacy-specific solutions, making it an indirect competitor to Prevounce in the broader healthcare management ecosystem. PharmD Live’s competitive edge lies in its specialized services and integration capabilities, often at a lower price point (KrowdBase).

Updox and Teladoc Health are also significant competitors, especially in remote patient monitoring and telehealth services. Updox offers communication and patient engagement tools with a focus on streamlining provider-patient interactions, while Teladoc emphasizes telehealth and virtual care, often at a premium price. Both are positioned to serve large healthcare organizations seeking scalable telehealth solutions, contrasting with Prevounce’s broader practice management focus (KrowdBase).

Overall, these competitors vary from direct rivals offering comprehensive EHR and practice management solutions to indirect competitors specializing in telehealth and remote monitoring, each with unique market strengths and pricing models.

Product & Pricing

Prevounce Health Product and Pricing Intelligence

Prevounce Health offers a comprehensive product suite focused on remote patient monitoring and healthcare management. As of 2026, their pricing structure includes various tiers, with detailed features and features differentiation between free and paid plans, although specific pricing figures are not publicly disclosed (saascounter, softwaresuggest). The platform emphasizes AI-powered insights and remote care capabilities, which are integrated into their paid plans, providing advanced features for healthcare providers.

Recent updates in 2025 and 2026 highlight that Prevounce has continuously enhanced its offerings, including the addition of AI-driven insights to improve remote care management (blog.prevounce.com). While exact recent pricing changes are not detailed, the company appears to maintain a tiered pricing model, offering different levels of service to cater to various healthcare provider needs. Free trial options or demo access are typically available, allowing potential users to evaluate the platform before committing to paid plans (findemr.com).

Overall, Prevounce Health's pricing and feature set are designed to support scalable healthcare solutions, with ongoing updates reflecting its commitment to innovation and customer needs in 2026.

Ad Campaigns

Prevounce Health Ad Campaigns

Prevounce Health is currently running 88 ads across Google, LinkedIn — 86 on Google and 2 on LinkedIn. Explore Prevounce Health's live ad creative, messaging, and the platforms they advertise on in the ad library — updated automatically by ForesightIQ.

See of Prevounce Health's ads

View ads

Hiring & Layoffs

Prevounce Health Hiring and Layoffs

Recent hiring trends at Prevounce Health indicate a focus on growth and expansion within the remote healthcare technology sector. The company has been actively hiring for roles such as Operations Manager, Bookkeeper, and Customer Success Director, reflecting a strategic emphasis on operational efficiency, financial management, and customer support (Prevounce Careers). Their workforce has grown by approximately 32.1% year-over-year, now comprising around 33 employees, which suggests a deliberate scaling of their team to support their expanding services and product offerings (Prevounce Revenue).

Despite the broader economic slowdown affecting hiring across many industries, Prevounce’s recent activity signals a resilient growth strategy, likely driven by their recent Series A funding round of $2.5 million in October 2023, aimed at scaling their AI-powered remote care platform and expanding their market reach (Prevounce Funding). Their focus on remote patient monitoring, chronic care management, and healthcare technology positions them well within the growing telehealth market, especially as demand for remote healthcare solutions continues to rise (Prevounce Blog).

There are no reports of recent layoffs at Prevounce Health, which suggests that their hiring patterns are aligned with a company strategy focused on growth and innovation rather than cost-cutting. Their ongoing recruitment and expansion efforts indicate a commitment to strengthening their leadership in remote healthcare services, leveraging AI and cellular-connected devices to meet increasing healthcare demands (Prevounce Web Presence). This strategic pattern signals a positive outlook for their future development in the competitive telehealth market.

Leadership

Prevounce Health Management and Leadership Team

Prevounce Health is led by a team of experienced executives, with Daniel Tashnek serving as the Co-founder and CEO, a position he has held since the company's inception (Crunchbase). The management team also includes key figures such as Emily Embry, VP of Operations, Gus Kluger, VP of Strategy & Business Development, Carl Bertrams, VP of Sales, and Casey Johnson (Prevounce About Us). As of 2026, there have been no publicly reported recent leadership changes or notable new hires at the C-suite level beyond these core executives (RocketReach). The company's leadership remains focused on strategic growth, evidenced by its impressive revenue increase to $12.1 million in 2024 (GetLatka). The board members and other leadership details are not explicitly listed in the available sources, but the company's executive team continues to drive its health management solutions forward.

Financials

Prevounce Health Financial Performance, Fundraising, M&A

As of April 2026, Prevounce Health has demonstrated significant growth and activity in funding and financial performance. In October 2023, the company raised approximately $7 million in a funding round aimed at scaling its remote care management solutions, reflecting strong investor confidence (Gaebler, HitConsultant). This funding round extended its Series A, indicating ongoing investor support and valuation growth (Prevounce Blog). The company's valuation at that time was not explicitly disclosed but can be inferred to be substantial given the $7 million raise and strategic growth focus (Growjo).

Regarding revenue figures, detailed current revenue data is not publicly available; however, previous reports from 2023 suggest that Prevounce was actively expanding its revenue streams through remote care management solutions. The company's financial health indicators, such as revenue growth and operational scaling, appear positive based on its continued funding rounds and strategic acquisitions (CB Insights). Additionally, there are no publicly reported acquisitions or mergers involving Prevounce Health as of April 2026, but the company's ongoing investments and funding rounds suggest a focus on growth and market expansion (Tracxn). Overall, Prevounce Health's financial trajectory indicates a healthy and expanding company in the digital health and remote care management sector.

Partnerships

Prevounce Health Partnerships, Clients and Vendors

Prevounce Health has established a robust network of partnerships, clients, and vendors that enhance its remote care management platform. Notably, Prevounce has partnered with Johnson Memorial Health to deliver comprehensive remote care for patients with chronic conditions, highlighting its focus on integrated healthcare solutions (Prevounce Blog). Additionally, Prevounce has joined the Elation Health Partner Hub, expanding its ecosystem relationships and technology integrations, which facilitates collaboration with other healthcare technology providers (Prevounce Blog).

Prevounce’s client base includes hospitals and health systems, as evidenced by case studies such as the New York Health System, demonstrating its enterprise-level client engagements (Prevounce Case Study). The company also maintains active collaborations with payors and other healthcare organizations, emphasizing its role in the broader healthcare ecosystem (Prevounce Payors).

In terms of technology integrations, Prevounce collaborates with various partners to enhance its platform’s capabilities, as seen in its participation in partner programs like the Elation Health Partner Hub and other integration initiatives (Elation Health Partners). These strategic alliances enable Prevounce to deliver comprehensive remote care solutions and expand its ecosystem relationships, positioning it as a key player in healthcare technology partnerships.

Events

Prevounce Health Event Participations

Prevounce Health actively participates in various industry events to promote remote patient monitoring and healthcare innovation. Notably, they hosted an on-demand webinar titled "Winning in Remote Care 2026: What Providers Must Know," which provides insights into remote care strategies for 2026 (Prevounce). Additionally, they published an article in early 2026 titled "Achieving Remote Care Success in 2026: Top Questions Answered," indicating ongoing engagement with the healthcare community and thought leadership in remote care (Prevounce Blog).

While specific details about conferences, trade shows, or community events they sponsor or attend are not explicitly listed in the search results, Prevounce's participation in prominent healthcare events such as HIMSS 2020 suggests their active presence at major industry gatherings (Prevounce Blog). Their involvement in these events underscores their commitment to engaging with healthcare providers and stakeholders to advance remote patient monitoring solutions.

Frequently Asked Questions

What does Prevounce Health's October 2023 Series A extension to $7M signal about investor conviction in its remote care model?

The $7M Series A extension signals sustained investor confidence in Prevounce's remote care management thesis at a time when many digital health companies were struggling to raise follow-on capital. Rather than a new round, this was an extension of an existing Series A, suggesting existing investors doubled down rather than forcing a new valuation negotiation — typically a sign that growth metrics were tracking to plan. The company reached $12.1M in reported revenue by 2024, lending credence to the view that the capital deployment was productive.

With only ~33 employees and $12.1M in revenue, how capital-efficient is Prevounce Health relative to peers, and what does that imply for acquirers?

At roughly $12.1M in revenue with approximately 33 employees, Prevounce is generating around $367K in revenue per employee — a ratio that sits well above the typical SaaS benchmark of $150K–$250K and signals a lean, high-utilization operating model. For a corp-dev team evaluating acquisition, this implies the business could absorb a buyer's sales and G&A infrastructure with minimal redundancy cost, and that the core platform is not headcount-intensive to operate. The flip side is that rapid scaling would require deliberate investment in people, given the current team is thin.

What does Prevounce Health's hiring pattern — Operations Manager, Bookkeeper, Customer Success Director — reveal about where the business is under stress or building for the next phase?

The combination of an Operations Manager, Bookkeeper, and Customer Success Director points to a company that has outgrown its startup-phase informal processes and is professionalizing its back office and retention functions simultaneously. The Bookkeeper role in particular is an unusual public hire for a venture-backed company and may indicate the finance function has been handled informally or outsourced to date — a gap that often surfaces during due diligence. The Customer Success Director role, hired alongside operational infrastructure, suggests churn management or expansion revenue within the existing customer base is a near-term strategic priority.

Prevounce's 32.1% year-over-year headcount growth is notable — does it reflect organic demand pull or funded land-grab, and how sustainable is it?

The 32.1% headcount growth, set against a $7M Series A extension in October 2023, looks more like funded land-grab than pure organic demand pull — the capital event preceded the hiring ramp. However, the absence of any reported layoffs and the concurrent rise in revenue to $12.1M by 2024 suggest the growth has been absorbed productively rather than resulting in the over-hiring that plagued many digital health firms post-2021. Sustainability will hinge on whether gross margins can support the expanded headcount once the Series A capital is deployed; detailed margin data is not publicly available.

What does Prevounce Health's partnership with Johnson Memorial Health and entry into the Elation Health Partner Hub reveal about its go-to-market evolution?

The Johnson Memorial Health partnership demonstrates that Prevounce is moving up-market toward integrated health systems for chronic care management, not just targeting independent physician practices. The Elation Health Partner Hub entry is a complementary signal: Elation is a primary-care-focused EHR with a strong independent practice base, so joining that ecosystem gives Prevounce distribution into a channel that is natural for remote patient monitoring and chronic care billing. Together, these moves suggest a dual go-to-market — direct enterprise deals with health systems and indirect channel penetration through EHR marketplaces.

How does Prevounce Health's competitive positioning against Updox and Teladoc Health hold up, given those players have far greater scale?

Prevounce's defensible position against Updox and Teladoc is product specificity rather than scale: it focuses narrowly on billable remote care programs — RPM, chronic care management, and preventive care billing — rather than competing on broad telehealth infrastructure. Teladoc and Updox are largely horizontal platforms where RPM is one feature among many, whereas Prevounce's workflow and reimbursement automation are purpose-built for that billing category. The risk is that large EHR vendors or telehealth platforms could bundle similar functionality at lower marginal cost; Prevounce's moat is execution depth and compliance-specific workflow, not platform breadth.

Prevounce Health's revenue reached $12.1M in 2024 — what growth rate does that imply, and does the trajectory support a growth or value acquisition frame?

Revenue of $12.1M in 2024, coming off a company that raised its Series A extension in late 2023, implies meaningful growth if earlier-stage revenue was in the low single-digit millions, though a precise prior-year figure is not publicly disclosed. The company's 32.1% headcount growth rate and continued product investment suggest this is positioned as a growth asset rather than a mature cash-flow story. For M&A framing, a buyer would likely apply a revenue multiple rather than EBITDA multiple, and the $7M total disclosed funding relative to $12.1M revenue indicates capital efficiency that keeps dilution risk low for an acquirer negotiating on enterprise value.

What does Prevounce Health's thought-leadership posture heading into 2026 — webinars on 'Winning in Remote Care 2026,' blog articles on top questions answered — signal about its pipeline strategy?

The forward-looking 2026 content strategy signals that Prevounce is deliberately positioning itself as the category-definition voice in remote care reimbursement ahead of anticipated CMS coding and reimbursement changes — a common tactic for companies whose sales cycle is tied to regulatory education. Providers who consume this content are often in the awareness or evaluation phase of adopting RPM billing programs, making the webinar series a top-of-funnel demand generation tool disguised as thought leadership. This approach is cost-effective at Prevounce's headcount and budget level, but it also reveals that the company relies heavily on inbound and education-led sales rather than an outbound enterprise sales motion.

Prevounce Health's product has added AI-powered insights — is this a genuine differentiator or a positioning response to market pressure?

The AI-powered insights addition, announced via a blog post and incorporated into the platform's paid tiers, is directionally consistent with what every remote patient monitoring vendor is claiming in 2025–2026, making it difficult to assess as a standalone differentiator without product-level diligence. What gives it more credibility in Prevounce's case is the narrow use case: AI applied specifically to RPM alert prioritization and care management workflow — not generalized health AI — which is a tractable problem with measurable clinical utility. Whether it constitutes a durable moat depends on whether the models are trained on Prevounce's own longitudinal patient data, which would create a data-network-effect barrier competitors cannot easily replicate.

What does Prevounce Health's engagement with health system clients like a New York Health System case study signal about where it sees its ceiling, and is the SMB or enterprise segment its true growth engine?

The New York Health System case study indicates Prevounce is willing to pursue and capable of closing enterprise-level accounts, which is a meaningful signal given that RPM reimbursement economics scale favorably with patient volume. However, its EHR marketplace presence via Elation Health — a platform dominated by independent and small-group practices — and its product positioning around making remote care 'easy and profitable for rural healthcare providers' suggest the core growth engine remains SMB and community health. The enterprise case studies appear to be reference accounts for credibility rather than the primary revenue driver, though a shift up-market is plausible with additional sales investment.

No acquisitions are on record for Prevounce Health — what does that absence signal about its build-versus-buy philosophy, and does it create an integration risk gap?

The absence of any acquisitions through April 2026 signals that Prevounce has pursued an organic build strategy, which at 33 employees and $7M in total disclosed funding is the only financially viable path — the company has not had the balance sheet for meaningful M&A. This creates both a risk and an opportunity: the platform is likely architecturally coherent with no integration debt from bolt-on deals, making it a cleaner target for an acquirer, but it may also have capability gaps in areas like data interoperability or care coordination tooling that a strategic buyer would need to assess. The Elation Health Partner Hub integration suggests the company is filling those gaps through partnerships rather than acquisitions.

Powered by ForesightIQ · Competitive intelligence from digital exhaust